List view / Grid view
11 October 2013 | By Abbott
"Malnutrition in children is associated with poor health outcomes and this is especially important in the hospitalized child..."
11 October 2013 | By AstraZeneca
AstraZeneca announced that it has entered into an agreement to co-promote, an innovative oral therapy for the treatment of patients with prostate cancer...
10 October 2013 | By Teva Pharmaceutical Industries Ltd
$2.0 billion in annual cost savings by the end of 2017 including $1.0 billion by the end of 2014...
9 October 2013 | By Pfizer
The brand’s latest innovation provides eight hours of moisture and contains advanced ingredient...
9 October 2013 | By Pfizer Inc.
“We are excited to see progress in our development program in psoriasis..."
9 October 2013 | By Gilead
"We are pleased that idelalisib has shown a clinically meaningful benefit for patients..."
8 October 2013 | By Merck
The survey revealed the importance of physicians and pharmacists in encouraging vaccination...
8 October 2013 | By Boehringer Ingelheim
"These results are promising particularly because they show the potential to evaluate harder-to-treat populations..."
8 October 2013 | By Janssen Pharmaceuticals, Inc
"We're excited to add GSK2336805 to our existing portfolio of direct-acting antivirals (DAAs)...
8 October 2013 | By Johnson & Johnson
Simeprevir works by blocking the protease enzyme that enables the hepatitis C virus to replicate in host cells...
8 October 2013 | By GlaxoSmithKline
These latest results demonstrated that over 18 months of follow-up, RTS,S was shown to almost halve the number of malaria cases...
8 October 2013 | By Tecan
Tecan announces the European launch of its Tecan Academy web-based training tool...
7 October 2013 | By Boehringer Ingelheim Corp
Ben Venue Laboratories, Inc has decided to cease production by the end of 2013...
7 October 2013 | By AstraZeneca
As previously announced, the acquisition bolsters MedImmune’s oncology pipeline...
Anticoagulants are an indispensable treatment to prevent dangerous blood clots that can cause devastating ischaemic strokes in patients with atrial fibrillation or life-threatening pulmonary embolism in patients with venous thromboembolism.1,2 An increased risk of bleeding is a known possible complication of all anticoagulant therapies.3 This research shows that applying existing…
